Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Screening for triploidy by fetal nuchal translucency and maternal serum free ?-hCG and PAPP-A at 10-14 weeks of gestation

1 Jan 2000

Abstract excerpt

In 25 cases of triploidy at 10-14 weeks of gestation, compared with 947 controls, the median multiple of the median (MoM) fetal nuchal translucency (NT) thickness was significantly increased (1.89 MoM), and maternal serum total and free beta-human chorionic gonadotrophin (hCG) were increased (3.13 MoM and 4.59 MoM respectively), alpha fetoprotein (AFP) was increased (2.14 MoM), and pregnancy associated plasma...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Gestational Trophoblastic Disease Studies
Share to Parvovirus B19 Infection Studies
Share to Prenatal Screening and Diagnostics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 10820411
DOI: 10.1002/1097-0223(200006)20:6<495::aid-pd846>3.0.co;2-u

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Screening for triploidy by fetal nuchal translucency and maternal serum free ?-hCG and PAPP-A at 10-14 weeks of gestationPMID 10820411Read ↗

First-trimester nuchal translucency and maternal serum free beta-hCG and PAPP-A can detect triploidy and determine the parental origin.Semantic proximity Read ↗

Prenatal sonographic features can accurately determine parental origin in triploid pregnancies.Semantic proximity Read ↗

Diagnosis and prediction of parental origin of triploidies by fetal nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11-14 weeks of gestation.Semantic proximity Read ↗

Triploid pregnancy-Clinical implications.Semantic proximity Read ↗

Screening for trisomy 13 by fetal nuchal translucency and maternal serum free ?-hCG and PAPP-A at 10-14 weeks of gestationSemantic proximity Read ↗

Screening for triploidy by the risk algorithms for trisomies 21, 18 and 13 at 11 weeks to 13 weeks and 6 days of gestationSemantic proximity Read ↗

Analysis of the spectrum of malformations in human fetuses of the second and third trimester of pregnancy with human triploidy.Semantic proximity Read ↗

Screening for trisomy 18 by fetal nuchal translucency and maternal serum free β -hCG and PAPP-A at 10-14 weeks of gestationSemantic proximity Read ↗

Increased nuchal translucency in euploid fetuses—what should we be telling the parents?Semantic proximity Read ↗

Second trimester maternal serum analytes in triploid pregnancies: correlation with phenotype and sex chromosome complement.Semantic proximity Read ↗

Maternal serum hCG and fetal nuchal translucency thickness for the prediction of fetal trisomies in the first trimester of pregnancySemantic proximity Read ↗

Increased nuchal translucency in fetuses with a normal karyotype—diagnosis and managementSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.